Showing results (291-300 of 307) with videos related to
Sort By:
Pageof 31
European Heart Journal. Digital Health|February 2, 2026
Impact and safety of remote monitoring of heart failure patients managed with the HeartLogic algorithm: the HeartLogic France Cohort StudyRodrigue Garcia, Daniel Gras, Jacques Mansourati, et al.Archives of Cardiovascular Diseases|September 6, 2016
Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators: Groupe de Rythmologie et Stimulation Cardiaque de la Société Française de Cardiologie and Société Française de Gériatrie et GérontologieLaurent Fauchier, Christine Alonso, Frederic Anselme, et al.Archives of Cardiovascular Diseases|January 31, 2025
Temporal trends in population characteristics and type of device among primary prevention implantable cardioverter defibrillator recipients: The DAI-PP programmeDiana My Frodi, Serge Boveda, Victor Fournier, et al.Heart (British Cardiac Society)|March 16, 2018
Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary preventionSérgio Barra, Rui Providência, Serge Boveda, et al.Journal of the American College of Cardiology|April 1, 2017
Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial SubstrateSérgio Barra, Serge Boveda, Rui Providência, et al.Archives of Cardiovascular Diseases|June 1, 2020
Joint Position Paper of the Working Group of Pacing and Electrophysiology of the French Society of Cardiology and the French Society of Diagnostic and Interventional Cardiac and Vascular Imaging on magnetic resonance imaging in patients with cardiac electronic implantable devicesEstelle Gandjbakhch, Jean-Nicolas Dacher, Jerome Taieb, et al.International Journal of Cardiology|April 7, 2018
Usefulness of a clinical risk score to predict the response to cardiac resynchronization therapyRui Providencia, Eloi Marijon, Sergio Barra, et al.Heart Rhythm O2|July 31, 2023
Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillatorMichael S Lloyd, Amy J Brisben, Vivek Y Reddy, et al.Journal of Arrhythmia|October 21, 2016
Erratum to '2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing' [Journal of Arrhythmia 32/1 (2016) 1-28]Bruce L Wilkoff, Laurent Fauchier, Martin K Stiles, et al.European Heart Journal|September 3, 2015
Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort studyEloi Marijon, Christophe Leclercq, Kumar Narayanan, et al.Pageof 31